266 results on '"Derfuss T"'
Search Results
2. Magnetic resonance imaging in immune-mediated myelopathies
3. Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment
4. P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions
5. The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis
6. Herpesviral Proteins Regulating Apoptosis
7. Magnetic resonance imaging in immune-mediated myelopathies
8. Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis
9. THUR 174 The magnify-ms study: mavenclad® tablets in active rms
10. S6D:4 Antibodies to myelin oligodendrocyte glycoprotein in patients with sle are associated with central nervous system involvement: an unbiased pilot study of the swiss sle cohort study (sscs)
11. ECTRIMS / EAN guideline on the pharmacological treatment of people with multiple sclerosis
12. Zelldepletion und Myeloablation bei neuroimmunologischen Erkrankungen
13. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
14. Supplement to: Multiple sclerosis and antibodies against KIR4.1.
15. MT-1303, a novel selective s1p1 receptor modulator in RRMS - results of a placebo controlled, double blind phase II trial (momentum)
16. Efficacy of fingolimod in patients with highly active relapsing–remitting multiple sclerosis
17. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
18. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
19. Myelin-oligodendrocyte glycoprotein antibody-associated disease
20. Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity
21. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
22. T-cell response against varicella-zoster virus in fingolimod-treated MS patients
23. Neurofascin as a target for autoantibodies in peripheral neuropathies
24. Aggressive multiple sclerosis (2): Treatment
25. Aggressive multiple sclerosis (1) : Towards a definition of the phenotype
26. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS
27. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
28. Anti-MOG autoantibodies in children with acute demyelination: Comparison of assays and longitudinal analysis
29. Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies
30. Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing
31. Differential Regulation of Mitochondrial Respiration and Cytochrome Redox State in Acute Pulmonary Oxygen Sensing.
32. Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis
33. Autoantigen- und erregerspezifische T- und B-Zellreaktionen bei multipler Sklerose: „Eine unendliche Geschichte”?
34. Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
35. Online regional myocardial blood flow measurement – Calibration of a near infrared laser doppler device and detection of coronary artery bypass occlusion in a porcine model
36. Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B–cell response
37. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions
38. Prevalence of HHV-6 in human sensory ganglia
39. 42: HHV-6 reactivation in the brain of patients with graft versus host disease
40. Immunoadsorption patients with multiple sclerosis: an open-label pilot study
41. Multiple Sklerose Chlamydien-Hypothese in der Diskussion: Chlamydien-Hypothese in der Diskussion
42. Multiple Sklerose
43. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response
44. Prevalence of HHV-6 in human sensory ganglia
45. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
46. Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment.
47. Epstein-Barr-negative MS: a true phenomenon?
48. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
49. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
50. Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler`s virus infections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.